Rabies Virus Glycoprotein

Send Inquiry
Rabies Virus Glycoprotein
Details
•CAS Number: 115136-25-9
•Synonyms: RVG29; RDP; Rabies virus glycoprotein 29 peptide; Blood-brain barrier penetrating peptide RVG
•Amino Acid Sequence: Tyr-Thr-Ile-Trp-Met-Pro-Glu-Asn-Pro-Arg-Pro-Gly-Thr-Pro-Cys-Asp-Ile-Phe-Thr-Asn-Ser-Arg-Gly-Lys-Arg-Ala-Ser-Asn-Gly (one-letter: YTIWMPENPRPGTPCDIFTNSRGKRASNG)
•Peptide Length: 29 amino acids
•Purity (HPLC): ≥95%
Related Documents
•Certificate of Analysis (COA)
•Mass Spectrometry (MS) Report
•HPLC Purity Report
•Peptide Solubility and Storage Guide
Category
Drug Delivery Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of rabies virus glycoprotein in China, also supports custom service. Welcome to wholesale bulk high quality rabies virus glycoprotein from our factory. Contact us for more details.

 

Description Rabies Virus Glycoprotein (RVG29) is a 29-amino-acid peptide derived from residues 189-214 of the rabies virus (RABV) glycoprotein, CAS number 115136-25-9. Rabies virus is highly neurotropic and can efficiently penetrate the blood-brain barrier (BBB) to invade the central nervous system, a mechanism related to the specific binding of the RVG29 peptide to α7 nicotinic acetylcholine receptors (α7-nAChR) on neuronal cell surfaces, followed by transcytosis across the BBB via receptor-mediated transcytosis (RMT). The RVG29 peptide retains the neural targeting and BBB penetration capabilities of rabies virus without viral pathogenicity, and is therefore widely used as a ligand for central nervous system targeted delivery. RVG29 can be conjugated or fused with nucleic acids (siRNA, shRNA, antisense oligonucleotides), proteins, peptide drugs, nanoparticles, and exosomes to efficiently deliver therapeutic cargoes to brain tissue, for therapeutic research in neurodegenerative diseases (such as Alzheimer's disease, Parkinson's disease), brain tumors, neuroinflammation, and central nervous system infections. RVG29 can also mediate the delivery of Mycobacterium tuberculosis antigens to antigen-presenting cells, enhancing immune responses.
Molecular formula C₁₄₁H₂₁₇N₄₃O₄₃S₂
Molecular weight (Da) 3266.70
Structure type Linear peptide (rabies virus glycoprotein-derived, α7-nAChR targeting, BBB penetrating peptide)
Solubility Soluble in water (below 1 mg/mL), PBS, DMSO
Storage Condition Powder at -20°C, dry and protected from light

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Core Structure Molecular Formula Exact Mass (Da) Average MW (Da) Salt Form Length (aa)
Rabies Virus Glycoprotein RVG peptide; rabies virus glycoprotein neural targeting peptide Neural targeting peptide, blood-brain barrier penetration, cell-penetrating peptide, CNS delivery 29-mer peptide derived from rabies virus glycoprotein containing a neural targeting motif; binds nicotinic acetylcholine receptors on neural cells and brain endothelial cells to mediate transport across the blood-brain barrier C₁₃₁H₂₁₄N₄₂O₃₉S 2988.58 ~2990.8 Acetate 29

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Powder Stability
PEP-RVG29 White powder Store at -20°C, sealed, dry and protected from light. Aliquot for storage. Stable for 1 month at 2–8°C in sealed dry condition; stable for shipping at ambient temperature. Stable for 7 days at 4°C. Soluble in dilute acetic acid and PBS. Optimal receptor binding activity at physiological pH; conformational change and binding activity loss under strong acid/base conditions. Stable for 2 years at -20°C, dry and protected from light.

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-RVG29 RVG rabies virus glycoprotein peptide targets nAChR to cross the blood-brain barrier RVG peptide is a neural-targeting penetrating peptide derived from rabies virus glycoprotein. It specifically binds nicotinic acetylcholine receptors on neurons and brain microvascular endothelial cells, and penetrates the blood-brain barrier via receptor-mediated transcytosis to deliver nucleic acids, proteins, nanoparticles and small molecule drugs into the central nervous system. It is a classic tool peptide for the treatment of central nervous system diseases and brain-targeted research. CNS drug delivery, blood-brain barrier penetration research, neurological disease therapy, brain-targeted drug development, gene therapy Nicotinic acetylcholine receptor (nAChR); receptor-mediated transcytosis; blood-brain barrier penetration

 

 

 

 

Hot Tags: rabies virus glycoprotein, China rabies virus glycoprotein manufacturers, suppliers, factory, 191936-91-1, 651328-78-8, MPG Peptide, NGR peptide, therapeutic and pharmaceutical peptides, Transportan

Send Inquiry